Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.1 - $10.0 $123,685 - $242,520
-24,252 Reduced 11.69%
183,217 $1.26 Million
Q1 2022

May 16, 2022

BUY
$8.34 - $14.69 $1.15 Million - $2.03 Million
137,979 Added 198.56%
207,469 $1.93 Million
Q4 2021

Feb 14, 2022

BUY
$13.6 - $24.89 $735,624 - $1.35 Million
54,090 Added 351.23%
69,490 $988,000
Q3 2021

Nov 15, 2021

BUY
$21.22 - $25.7 $326,788 - $395,780
15,400 New
15,400 $357,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.